|
1 Company |
|
0 Products |
|
0 Products |
|
3 Mechanisms of Action |
|
0 Trials |
|
13 News |
|
- | NN1213 / Novo Nordisk
Trial completion: Characterization of Childhood-Onset Obsessive-Compulsive Disorder (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=49, Completed, Sponsor: National Institute of Mental Health (NIMH)
Active, not recruiting --> Completed
- |||| Trial completion, Real-world evidence, Real-world: PANDA-III: Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in "Real-World" Practice (clinicaltrials.gov) - Mar 14, 2016
P4, N=2348, Completed, Sponsor: Sino Medical Sciences Technology Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- | azithromycin / Generic mfg.
Trial completion, Enrollment change: Antibiotic Treatment Trial for the PANDAS/PANS Phenotype (clinicaltrials.gov) - Feb 5, 2015
P2, N=47, Completed, Sponsor: University of South Florida
Recruiting --> Completed Active, not recruiting --> Completed | N=100 --> 47
- ||| Trial completion: Panda: Evaluation of a Smartphone-based Perioperative Pain Assessment Tool (clinicaltrials.gov) - Jan 20, 2015
P=N/A, N=144, Completed, Sponsor: University of British Columbia
Active, not recruiting --> Completed | N=100 --> 47 Active, not recruiting --> Completed
- ||| azithromycin / Generic mfg.
Enrollment closed, Trial primary completion date: Antibiotic Treatment Trial for the PANDAS/PANS Phenotype (clinicaltrials.gov) - Dec 19, 2014
P2, N=100, Active, not recruiting, Sponsor: University of South Florida
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Jan 2015
- azithromycin / Generic mfg.
Trial primary completion date: Antibiotic Treatment Trial for the PANDAS/PANS Phenotype (clinicaltrials.gov) - May 5, 2014
P2, N=100, Recruiting, Sponsor: University of South Florida
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Jan 2015 Trial primary completion date: Jun 2014 --> Aug 2014
- azithromycin / Generic mfg.
Trial completion date: Antibiotic Treatment Trial for the PANDAS/PANS Phenotype (clinicaltrials.gov) - May 5, 2014
P2, N=100, Recruiting, Sponsor: University of South Florida
Trial primary completion date: Jun 2014 --> Aug 2014 Trial completion date: Jun 2014 --> Aug 2014
- Enrollment change: Panda: Evaluation of a Smartphone-based Perioperative Pain Assessment Tool (clinicaltrials.gov) - Mar 17, 2014
P=N/A, N=144, Active, not recruiting, Sponsor: University of British Columbia
Trial completion date: Jun 2014 --> Aug 2014 N=200 --> 144
- Enrollment closed: Panda: Evaluation of a Smartphone-based Perioperative Pain Assessment Tool (clinicaltrials.gov) - Mar 17, 2014
P=N/A, N=144, Active, not recruiting, Sponsor: University of British Columbia
N=200 --> 144 Recruiting --> Active, not recruiting
- | NN1213 / Novo Nordisk
Trial completion: Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup) (clinicaltrials.gov) - Feb 19, 2014
P2, N=90, Completed, Sponsor: National Institute of Mental Health (NIMH)
Recruiting --> Active, not recruiting No longer recruiting --> Completed
- ||||| New P4 trial, Real-world evidence, Real-world: PANDA-III: Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in "Real-World" Practice (clinicaltrials.gov) - Dec 18, 2013
P4, N=2350, Recruiting, Sponsor: Sino Medical Sciences Technology Inc.
- | azithromycin / Generic mfg.
New P2 trial: Antibiotic Treatment Trial for the PANDAS/PANS Phenotype (clinicaltrials.gov) - Jun 10, 2012
P2, N=100, Recruiting, Sponsor: University of South Florida